A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial

OBJECTIVE:Protocolized sedation (PS) and daily sedative interruption (DI) in critically ill patients have both been shown to shorten the durations of mechanical ventilation (MV) and intensive care unit (ICU) stay. Our objective was to determine the safety and feasibility of a randomized trial to det...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2008-07, Vol.36 (7), p.2092-2099
Hauptverfasser: Mehta, Sangeeta, Burry, Lisa, Martinez-Motta, J Carlos, Stewart, Thomas E, Hallett, David, McDonald, Ellen, Clarke, France, MacDonald, Rod, Granton, John, Matte, Andrea, Wong, Cindy, Suri, Amit, Cook, Deborah J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2099
container_issue 7
container_start_page 2092
container_title Critical care medicine
container_volume 36
creator Mehta, Sangeeta
Burry, Lisa
Martinez-Motta, J Carlos
Stewart, Thomas E
Hallett, David
McDonald, Ellen
Clarke, France
MacDonald, Rod
Granton, John
Matte, Andrea
Wong, Cindy
Suri, Amit
Cook, Deborah J
description OBJECTIVE:Protocolized sedation (PS) and daily sedative interruption (DI) in critically ill patients have both been shown to shorten the durations of mechanical ventilation (MV) and intensive care unit (ICU) stay. Our objective was to determine the safety and feasibility of a randomized trial to determine whether adults managed with both PS + DI have a shorter duration of MV than patients managed with PS alone. DESIGN:Prospective randomized, concealed, unblinded, multicenter, pilot trial. SETTING:Three university-affiliated medical-surgical ICUs. PATIENTS:Sixty-five adults anticipated to require MV >48 hrs and receiving sedative/analgesic infusions. INTERVENTIONS:Patients were randomized to PS alone, or PS + DI. PS was implemented by bedside nurses; sedatives/analgesics were titrated to achieve Sedation Agitation Score (SAS) 3–4. The PS + DI group also had infusions interrupted daily until the patients awoke. MEASUREMENTS AND MAIN RESULTS:Diagnosis, age [mean ± sd] (53 ± 18.3 vs. 62.1 ± 16.7 yrs) and Acute Physiology and Chronic Health Evaluation II (27.7 ± 8.4 vs. 26.6 ± 8.4) were similar in the PS and PS + DI groups, respectively. The median duration of MV in the PS and PS + DI groups was 8.0 vs. 10.5 days, and ICU stay was 10.0 vs. 13.0 days, respectively. The SAS was within target range (3–4) in 59% of 9,611 measurements, and within an acceptable range (2–5) in 86% of measurements. Self-assessed nursing and respiratory therapist workload was low in the majority of the cohort. Adverse events were similar in both groups. Patient recruitment was slower than projected (1.5 patients/mo). CONCLUSION:This pilot trial comparing PS vs. PS + DI confirmed the safety and acceptability of the sedation protocol and DI, and guided important modifications to the protocol, thus enhancing the feasibility of a future multicenter trial. This trial was not designed to detect small but significant differences in clinically important outcomes.
doi_str_mv 10.1097/CCM.0b013e31817bff85
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69286974</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69286974</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3845-610391d617b4f783e371ee2add5e90ea7a8de5d5cf82218d951aa9bc91dc90763</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi1ERbeFN0DIF7ilteM4trmtVoUiFXGBczRrT7qmThxsr1bt09doVyBx4GRp_P2_Zj5C3nJ2xZlR15vN1yu2ZVyg4Jqr7Thq-YKsuBSsYa0RL8mKMcMa0RlxTi5y_skY76QSr8g511K2vVYrsqxpgtnFyT-hoyV5CDSO1IEPjxQO8ICzn--pn6lNvngLoc59CHSB4nEumU4ww33NHnzZUaAZXf2JM11SLNHG8JGu6eJDLMf21-RshJDxzem9JD8-3Xzf3DZ33z5_2azvGit0J5ueM2G46-th3ah0PVJxxBack2gYggLtUDppR922XDsjOYDZ2pqxhqleXJIPx966x6895jJMPlsMAWaM-zz0ptW9UV0FuyNoU8w54TgsyU-QHgfOht-mh2p6-Nd0jb079e-3E7q_oZPaCrw_AZCrtrFqtj7_4VrWma5npnL6yB1iKJjyQ9gfMA07hFB2_9_hGTeUmzk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69286974</pqid></control><display><type>article</type><title>A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Mehta, Sangeeta ; Burry, Lisa ; Martinez-Motta, J Carlos ; Stewart, Thomas E ; Hallett, David ; McDonald, Ellen ; Clarke, France ; MacDonald, Rod ; Granton, John ; Matte, Andrea ; Wong, Cindy ; Suri, Amit ; Cook, Deborah J</creator><creatorcontrib>Mehta, Sangeeta ; Burry, Lisa ; Martinez-Motta, J Carlos ; Stewart, Thomas E ; Hallett, David ; McDonald, Ellen ; Clarke, France ; MacDonald, Rod ; Granton, John ; Matte, Andrea ; Wong, Cindy ; Suri, Amit ; Cook, Deborah J ; Canadian Critical Care Trials Group</creatorcontrib><description>OBJECTIVE:Protocolized sedation (PS) and daily sedative interruption (DI) in critically ill patients have both been shown to shorten the durations of mechanical ventilation (MV) and intensive care unit (ICU) stay. Our objective was to determine the safety and feasibility of a randomized trial to determine whether adults managed with both PS + DI have a shorter duration of MV than patients managed with PS alone. DESIGN:Prospective randomized, concealed, unblinded, multicenter, pilot trial. SETTING:Three university-affiliated medical-surgical ICUs. PATIENTS:Sixty-five adults anticipated to require MV &gt;48 hrs and receiving sedative/analgesic infusions. INTERVENTIONS:Patients were randomized to PS alone, or PS + DI. PS was implemented by bedside nurses; sedatives/analgesics were titrated to achieve Sedation Agitation Score (SAS) 3–4. The PS + DI group also had infusions interrupted daily until the patients awoke. MEASUREMENTS AND MAIN RESULTS:Diagnosis, age [mean ± sd] (53 ± 18.3 vs. 62.1 ± 16.7 yrs) and Acute Physiology and Chronic Health Evaluation II (27.7 ± 8.4 vs. 26.6 ± 8.4) were similar in the PS and PS + DI groups, respectively. The median duration of MV in the PS and PS + DI groups was 8.0 vs. 10.5 days, and ICU stay was 10.0 vs. 13.0 days, respectively. The SAS was within target range (3–4) in 59% of 9,611 measurements, and within an acceptable range (2–5) in 86% of measurements. Self-assessed nursing and respiratory therapist workload was low in the majority of the cohort. Adverse events were similar in both groups. Patient recruitment was slower than projected (1.5 patients/mo). CONCLUSION:This pilot trial comparing PS vs. PS + DI confirmed the safety and acceptability of the sedation protocol and DI, and guided important modifications to the protocol, thus enhancing the feasibility of a future multicenter trial. This trial was not designed to detect small but significant differences in clinically important outcomes.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/CCM.0b013e31817bff85</identifier><identifier>PMID: 18552687</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Biological and medical sciences ; Clinical death. Palliative care. Organ gift and preservation ; Conscious Sedation - adverse effects ; Conscious Sedation - classification ; Conscious Sedation - methods ; Critical Care - methods ; Female ; Hospital Mortality ; Humans ; Hypnotics and Sedatives ; Intensive care medicine ; Intensive Care Units ; Male ; Medical sciences ; Midazolam ; Middle Aged ; Morphine ; Neuromuscular Blocking Agents - pharmacology ; Pilot Projects ; Respiration, Artificial ; Safety ; Sleep - drug effects</subject><ispartof>Critical care medicine, 2008-07, Vol.36 (7), p.2092-2099</ispartof><rights>2008 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3845-610391d617b4f783e371ee2add5e90ea7a8de5d5cf82218d951aa9bc91dc90763</citedby><cites>FETCH-LOGICAL-c3845-610391d617b4f783e371ee2add5e90ea7a8de5d5cf82218d951aa9bc91dc90763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20494609$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18552687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehta, Sangeeta</creatorcontrib><creatorcontrib>Burry, Lisa</creatorcontrib><creatorcontrib>Martinez-Motta, J Carlos</creatorcontrib><creatorcontrib>Stewart, Thomas E</creatorcontrib><creatorcontrib>Hallett, David</creatorcontrib><creatorcontrib>McDonald, Ellen</creatorcontrib><creatorcontrib>Clarke, France</creatorcontrib><creatorcontrib>MacDonald, Rod</creatorcontrib><creatorcontrib>Granton, John</creatorcontrib><creatorcontrib>Matte, Andrea</creatorcontrib><creatorcontrib>Wong, Cindy</creatorcontrib><creatorcontrib>Suri, Amit</creatorcontrib><creatorcontrib>Cook, Deborah J</creatorcontrib><creatorcontrib>Canadian Critical Care Trials Group</creatorcontrib><title>A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE:Protocolized sedation (PS) and daily sedative interruption (DI) in critically ill patients have both been shown to shorten the durations of mechanical ventilation (MV) and intensive care unit (ICU) stay. Our objective was to determine the safety and feasibility of a randomized trial to determine whether adults managed with both PS + DI have a shorter duration of MV than patients managed with PS alone. DESIGN:Prospective randomized, concealed, unblinded, multicenter, pilot trial. SETTING:Three university-affiliated medical-surgical ICUs. PATIENTS:Sixty-five adults anticipated to require MV &gt;48 hrs and receiving sedative/analgesic infusions. INTERVENTIONS:Patients were randomized to PS alone, or PS + DI. PS was implemented by bedside nurses; sedatives/analgesics were titrated to achieve Sedation Agitation Score (SAS) 3–4. The PS + DI group also had infusions interrupted daily until the patients awoke. MEASUREMENTS AND MAIN RESULTS:Diagnosis, age [mean ± sd] (53 ± 18.3 vs. 62.1 ± 16.7 yrs) and Acute Physiology and Chronic Health Evaluation II (27.7 ± 8.4 vs. 26.6 ± 8.4) were similar in the PS and PS + DI groups, respectively. The median duration of MV in the PS and PS + DI groups was 8.0 vs. 10.5 days, and ICU stay was 10.0 vs. 13.0 days, respectively. The SAS was within target range (3–4) in 59% of 9,611 measurements, and within an acceptable range (2–5) in 86% of measurements. Self-assessed nursing and respiratory therapist workload was low in the majority of the cohort. Adverse events were similar in both groups. Patient recruitment was slower than projected (1.5 patients/mo). CONCLUSION:This pilot trial comparing PS vs. PS + DI confirmed the safety and acceptability of the sedation protocol and DI, and guided important modifications to the protocol, thus enhancing the feasibility of a future multicenter trial. This trial was not designed to detect small but significant differences in clinically important outcomes.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Clinical death. Palliative care. Organ gift and preservation</subject><subject>Conscious Sedation - adverse effects</subject><subject>Conscious Sedation - classification</subject><subject>Conscious Sedation - methods</subject><subject>Critical Care - methods</subject><subject>Female</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hypnotics and Sedatives</subject><subject>Intensive care medicine</subject><subject>Intensive Care Units</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Midazolam</subject><subject>Middle Aged</subject><subject>Morphine</subject><subject>Neuromuscular Blocking Agents - pharmacology</subject><subject>Pilot Projects</subject><subject>Respiration, Artificial</subject><subject>Safety</subject><subject>Sleep - drug effects</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAQhi1ERbeFN0DIF7ilteM4trmtVoUiFXGBczRrT7qmThxsr1bt09doVyBx4GRp_P2_Zj5C3nJ2xZlR15vN1yu2ZVyg4Jqr7Thq-YKsuBSsYa0RL8mKMcMa0RlxTi5y_skY76QSr8g511K2vVYrsqxpgtnFyT-hoyV5CDSO1IEPjxQO8ICzn--pn6lNvngLoc59CHSB4nEumU4ww33NHnzZUaAZXf2JM11SLNHG8JGu6eJDLMf21-RshJDxzem9JD8-3Xzf3DZ33z5_2azvGit0J5ueM2G46-th3ah0PVJxxBack2gYggLtUDppR922XDsjOYDZ2pqxhqleXJIPx966x6895jJMPlsMAWaM-zz0ptW9UV0FuyNoU8w54TgsyU-QHgfOht-mh2p6-Nd0jb079e-3E7q_oZPaCrw_AZCrtrFqtj7_4VrWma5npnL6yB1iKJjyQ9gfMA07hFB2_9_hGTeUmzk</recordid><startdate>200807</startdate><enddate>200807</enddate><creator>Mehta, Sangeeta</creator><creator>Burry, Lisa</creator><creator>Martinez-Motta, J Carlos</creator><creator>Stewart, Thomas E</creator><creator>Hallett, David</creator><creator>McDonald, Ellen</creator><creator>Clarke, France</creator><creator>MacDonald, Rod</creator><creator>Granton, John</creator><creator>Matte, Andrea</creator><creator>Wong, Cindy</creator><creator>Suri, Amit</creator><creator>Cook, Deborah J</creator><general>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200807</creationdate><title>A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial</title><author>Mehta, Sangeeta ; Burry, Lisa ; Martinez-Motta, J Carlos ; Stewart, Thomas E ; Hallett, David ; McDonald, Ellen ; Clarke, France ; MacDonald, Rod ; Granton, John ; Matte, Andrea ; Wong, Cindy ; Suri, Amit ; Cook, Deborah J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3845-610391d617b4f783e371ee2add5e90ea7a8de5d5cf82218d951aa9bc91dc90763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Clinical death. Palliative care. Organ gift and preservation</topic><topic>Conscious Sedation - adverse effects</topic><topic>Conscious Sedation - classification</topic><topic>Conscious Sedation - methods</topic><topic>Critical Care - methods</topic><topic>Female</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hypnotics and Sedatives</topic><topic>Intensive care medicine</topic><topic>Intensive Care Units</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Midazolam</topic><topic>Middle Aged</topic><topic>Morphine</topic><topic>Neuromuscular Blocking Agents - pharmacology</topic><topic>Pilot Projects</topic><topic>Respiration, Artificial</topic><topic>Safety</topic><topic>Sleep - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehta, Sangeeta</creatorcontrib><creatorcontrib>Burry, Lisa</creatorcontrib><creatorcontrib>Martinez-Motta, J Carlos</creatorcontrib><creatorcontrib>Stewart, Thomas E</creatorcontrib><creatorcontrib>Hallett, David</creatorcontrib><creatorcontrib>McDonald, Ellen</creatorcontrib><creatorcontrib>Clarke, France</creatorcontrib><creatorcontrib>MacDonald, Rod</creatorcontrib><creatorcontrib>Granton, John</creatorcontrib><creatorcontrib>Matte, Andrea</creatorcontrib><creatorcontrib>Wong, Cindy</creatorcontrib><creatorcontrib>Suri, Amit</creatorcontrib><creatorcontrib>Cook, Deborah J</creatorcontrib><creatorcontrib>Canadian Critical Care Trials Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehta, Sangeeta</au><au>Burry, Lisa</au><au>Martinez-Motta, J Carlos</au><au>Stewart, Thomas E</au><au>Hallett, David</au><au>McDonald, Ellen</au><au>Clarke, France</au><au>MacDonald, Rod</au><au>Granton, John</au><au>Matte, Andrea</au><au>Wong, Cindy</au><au>Suri, Amit</au><au>Cook, Deborah J</au><aucorp>Canadian Critical Care Trials Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2008-07</date><risdate>2008</risdate><volume>36</volume><issue>7</issue><spage>2092</spage><epage>2099</epage><pages>2092-2099</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE:Protocolized sedation (PS) and daily sedative interruption (DI) in critically ill patients have both been shown to shorten the durations of mechanical ventilation (MV) and intensive care unit (ICU) stay. Our objective was to determine the safety and feasibility of a randomized trial to determine whether adults managed with both PS + DI have a shorter duration of MV than patients managed with PS alone. DESIGN:Prospective randomized, concealed, unblinded, multicenter, pilot trial. SETTING:Three university-affiliated medical-surgical ICUs. PATIENTS:Sixty-five adults anticipated to require MV &gt;48 hrs and receiving sedative/analgesic infusions. INTERVENTIONS:Patients were randomized to PS alone, or PS + DI. PS was implemented by bedside nurses; sedatives/analgesics were titrated to achieve Sedation Agitation Score (SAS) 3–4. The PS + DI group also had infusions interrupted daily until the patients awoke. MEASUREMENTS AND MAIN RESULTS:Diagnosis, age [mean ± sd] (53 ± 18.3 vs. 62.1 ± 16.7 yrs) and Acute Physiology and Chronic Health Evaluation II (27.7 ± 8.4 vs. 26.6 ± 8.4) were similar in the PS and PS + DI groups, respectively. The median duration of MV in the PS and PS + DI groups was 8.0 vs. 10.5 days, and ICU stay was 10.0 vs. 13.0 days, respectively. The SAS was within target range (3–4) in 59% of 9,611 measurements, and within an acceptable range (2–5) in 86% of measurements. Self-assessed nursing and respiratory therapist workload was low in the majority of the cohort. Adverse events were similar in both groups. Patient recruitment was slower than projected (1.5 patients/mo). CONCLUSION:This pilot trial comparing PS vs. PS + DI confirmed the safety and acceptability of the sedation protocol and DI, and guided important modifications to the protocol, thus enhancing the feasibility of a future multicenter trial. This trial was not designed to detect small but significant differences in clinically important outcomes.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</pub><pmid>18552687</pmid><doi>10.1097/CCM.0b013e31817bff85</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 2008-07, Vol.36 (7), p.2092-2099
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_69286974
source MEDLINE; Journals@Ovid Complete
subjects Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
APACHE
Biological and medical sciences
Clinical death. Palliative care. Organ gift and preservation
Conscious Sedation - adverse effects
Conscious Sedation - classification
Conscious Sedation - methods
Critical Care - methods
Female
Hospital Mortality
Humans
Hypnotics and Sedatives
Intensive care medicine
Intensive Care Units
Male
Medical sciences
Midazolam
Middle Aged
Morphine
Neuromuscular Blocking Agents - pharmacology
Pilot Projects
Respiration, Artificial
Safety
Sleep - drug effects
title A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: A pilot trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A57%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20randomized%20trial%20of%20daily%20awakening%20in%20critically%20ill%20patients%20managed%20with%20a%20sedation%20protocol:%20A%20pilot%20trial&rft.jtitle=Critical%20care%20medicine&rft.au=Mehta,%20Sangeeta&rft.aucorp=Canadian%20Critical%20Care%20Trials%20Group&rft.date=2008-07&rft.volume=36&rft.issue=7&rft.spage=2092&rft.epage=2099&rft.pages=2092-2099&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/CCM.0b013e31817bff85&rft_dat=%3Cproquest_cross%3E69286974%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69286974&rft_id=info:pmid/18552687&rfr_iscdi=true